Hemin-Induced Death Models Hemorrhagic Stroke and Is a Variant of Classical Neuronal Ferroptosis

• Published in: The Journal of neuroscience 2022-03, Vol.42 (10), p.2065-2079
• Main Authors: Zille, Marietta, Oses-Prieto, Juan A, Savage, Sara R, Karuppagounder, Saravanan S, Chen, Yingxin, Kumar, Amit, Morris, John H, Scheidt, Karl A, Burlingame, Alma L, Ratan, Rajiv R
• Format: Article
• Language: English
• Subjects: Animals; Antioxidants; Antioxidants - metabolism; Arachidonate 5-lipoxygenase; Brain; Caspase; Cell death; Depletion; Deprivation; Enzyme inhibitors; Extracellular signal-regulated kinase; Extracellular Signal-Regulated MAP Kinases - metabolism; Ferroptosis; Glutathione; Glutathione - metabolism; Glutathione peroxidase; Head injuries; Hemin; Hemin - metabolism; Hemin - pharmacology; Hemoglobin; Hemoglobins - metabolism; Hemorrhage; Hemorrhagic Stroke; Huntingtons disease; Intracranial Hemorrhages - metabolism; Iron - metabolism; Kinases; Lipoxygenase; Male; MAP kinase; MAP kinase phosphatase; MEK inhibitors; Mice; Mitogen-Activated Protein Kinase Kinases - metabolism; Necrosis; Necrosis - metabolism; Neurons; Neurons - metabolism; Peroxidase; Phosphorylation; Recovery of function; Stroke; Transcription; Translocation; Traumatic brain injury
• ISSN: 0270-6474; 1529-2401; 1529-2401
• DOI: 10.1523/JNEUROSCI.0923-20.2021

Ferroptosis is a caspase-independent, iron-dependent form of regulated necrosis extant in traumatic brain injury, Huntington disease, and hemorrhagic stroke. It can be activated by cystine deprivation leading to glutathione depletion, the insufficiency of the antioxidant glutathione peroxidase-4, and the hemolysis products hemoglobin and hemin. A cardinal feature of ferroptosis is extracellular signal-regulated kinase (ERK)1/2 activation culminating in its translocation to the nucleus. We have previously confirmed that the mitogen-activated protein (MAP) kinase kinase (MEK) inhibitor U0126 inhibits persistent ERK1/2 phosphorylation and ferroptosis. Here, we show that hemin exposure, a model of secondary injury in brain hemorrhage and ferroptosis, activated ERK1/2 in mouse neurons. Accordingly, MEK inhibitor U0126 protected against hemin-induced ferroptosis. Unexpectedly, U0126 prevented hemin-induced ferroptosis independent of its ability to inhibit ERK1/2 signaling. In contrast to classical ferroptosis in neurons or cancer cells, chemically diverse inhibitors of MEK did not block hemin-induced ferroptosis, nor did the forced expression of the ERK-selective MAP kinase phosphatase (MKP)3. We conclude that hemin or hemoglobin-induced ferroptosis, unlike glutathione depletion, is ERK1/2-independent. Together with recent studies, our findings suggest the existence of a novel subtype of neuronal ferroptosis relevant to bleeding in the brain that is 5-lipoxygenase-dependent, ERK-independent, and transcription-independent. Remarkably, our unbiased phosphoproteome analysis revealed dramatic differences in phosphorylation induced by two ferroptosis subtypes. As U0126 also reduced cell death and improved functional recovery after hemorrhagic stroke in male mice, our analysis also provides a template on which to build a search for U0126's effects in a variant of neuronal ferroptosis. Ferroptosis is an iron-dependent mechanism of regulated necrosis that has been linked to hemorrhagic stroke. Common features of ferroptotic death induced by diverse stimuli are the depletion of the antioxidant glutathione, production of lipoxygenase-dependent reactive lipids, sensitivity to iron chelation, and persistent activation of extracellular signal-regulated kinase (ERK) signaling. Unlike classical ferroptosis induced in neurons or cancer cells, here we show that ferroptosis induced by hemin is ERK-independent. Paradoxically, the canonical MAP kinase kinase (MEK) inhibitor U0126 b